<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>THE "NEW"  PROSTATE CANCER INFOLINK</title>
	<atom:link href="http://prostatecancerinfolink.net/feed/" rel="self" type="application/rss+xml" />
	<link>http://prostatecancerinfolink.net</link>
	<description></description>
	<pubDate>Sat, 19 Jul 2008 16:38:08 +0000</pubDate>
	<generator>http://wordpress.org/?v=MU</generator>
	<language>en</language>
			<item>
		<title>Your Saturday prostate cancer update</title>
		<link>http://prostatecancerinfolink.net/2008/07/19/your-weekend-prostate-cancer-update/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/19/your-weekend-prostate-cancer-update/#comments</comments>
		<pubDate>Sat, 19 Jul 2008 13:05:56 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Drugs in development]]></category>

		<category><![CDATA[Management]]></category>

		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=660</guid>
		<description><![CDATA[Recent publications have addressed the relative value of proton beam radiation compared to intensity modulated RT; the potential of vitamin D as a prostate cancer therapeutic agent; post-treatment quality of life issues; and the future potential of micro-RNA molecules. 
Nguyen et al. have published an up-to-date summary of the available pros and cons of proton beam [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/19/your-weekend-prostate-cancer-update/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Results of docetaxel + rapid androgen cycling trial not promising</title>
		<link>http://prostatecancerinfolink.net/2008/07/18/results-of-docetaxel-rapid-androgen-cycling-trial-not-promising/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/18/results-of-docetaxel-rapid-androgen-cycling-trial-not-promising/#comments</comments>
		<pubDate>Fri, 18 Jul 2008 21:55:31 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Drugs in development]]></category>

		<category><![CDATA[Management]]></category>

		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=655</guid>
		<description><![CDATA[Rathkopf et al. have reported the results of a phase II trial of docetaxel in combination with rapid androgen cycling in patients with progressive, non-castrate prostate cancer. Patients in this trial exhibited a high incidence of high-grade febrile neutropenia, making it unlikely that this form of treatment has potential in the management of patients with [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/18/results-of-docetaxel-rapid-androgen-cycling-trial-not-promising/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Surgical management of incontinence after localized therapy</title>
		<link>http://prostatecancerinfolink.net/2008/07/18/surgical-treatment-of-post-rp-incontinence-reviewed/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/18/surgical-treatment-of-post-rp-incontinence-reviewed/#comments</comments>
		<pubDate>Fri, 18 Jul 2008 11:55:46 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Living with Prostate Cancer]]></category>

		<category><![CDATA[Management]]></category>

		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=641</guid>
		<description><![CDATA[While large numbers of men will have immediate, short-term urinary incontinence following radical prostatectomy and other forms of treatment for localized prostate cancer, this will largely resolve in time for the majority of men. However, a small percentage of patients will suffer from significant long-term urinary incontinence.
At the recently completed 4th International Conference on Incontinence, [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/18/surgical-treatment-of-post-rp-incontinence-reviewed/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>The prostate cancer &#8220;news de jour&#8221;</title>
		<link>http://prostatecancerinfolink.net/2008/07/17/the-prostate-cancer-news-de-jour/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/17/the-prostate-cancer-news-de-jour/#comments</comments>
		<pubDate>Thu, 17 Jul 2008 12:48:38 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Management]]></category>

		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=631</guid>
		<description><![CDATA[Four recently published studies provide updates on selected topics of interest. 
An Australian group (Sharpley et al.) set out to develop a psychological questionnaire that specifically addressed issues related to the effects of prostate cancer on lifestyle. It is well understood that depression among prostate cancer patients can be a major source of distress for the patients [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/17/the-prostate-cancer-news-de-jour/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>New imaging technique has potential in PCa</title>
		<link>http://prostatecancerinfolink.net/2008/07/16/new-imaging-technique-shows-promise-in-pca/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/16/new-imaging-technique-shows-promise-in-pca/#comments</comments>
		<pubDate>Wed, 16 Jul 2008 18:56:12 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Management]]></category>

		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=627</guid>
		<description><![CDATA[A new imaging technique, which has been developed on an engineered version of the common cold virus, may (at some time in the next few years, but not soon) be able to assist in the early detection of lymph node positive prostate cancer. If this is the case, there is the potential for more effective treatment decisions for men [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/16/new-imaging-technique-shows-promise-in-pca/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Provenge as treatment for localized disease?</title>
		<link>http://prostatecancerinfolink.net/2008/07/16/provenge-as-treatment-for-localized-disease/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/16/provenge-as-treatment-for-localized-disease/#comments</comments>
		<pubDate>Wed, 16 Jul 2008 18:27:05 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Drugs in development]]></category>

		<category><![CDATA[Management]]></category>

		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=621</guid>
		<description><![CDATA[According to a corporate press release just issued, Dendreon has initiated a Phase 2 trial of PROVENGE® (sipuleucel-T) in men with localized prostate cancer who are scheduled to undergo a radical prostatectomy. The so-called NeoACT (NEOadjuvant Active Cellular immunoTherapy) trial will be conducted at the UCSF Helen Diller Family Comprehensive Cancer Center, and will enroll approximately [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/16/provenge-as-treatment-for-localized-disease/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Prostasol: a risk for blood clots?</title>
		<link>http://prostatecancerinfolink.net/2008/07/15/prostasol-a-risk-for-blood-clots/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/15/prostasol-a-risk-for-blood-clots/#comments</comments>
		<pubDate>Tue, 15 Jul 2008 14:01:21 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Living with Prostate Cancer]]></category>

		<category><![CDATA[Management]]></category>

		<category><![CDATA[Tips]]></category>

		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=617</guid>
		<description><![CDATA[A report has just been published regarding two recent cases of venous thromboembolism in men self-medicating with &#8220;Dr. Donsbach&#8217;s Prostasol.&#8221; Patients who are using or who are considering using this product should be aware of this possibility, as should their physicians. Any patient who is taking this product as a complementary or alternative medicine would be [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/15/prostasol-a-risk-for-blood-clots/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>How valuable is the PCA3 test?</title>
		<link>http://prostatecancerinfolink.net/2008/07/15/how-valuable-is-the-pca3-test/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/15/how-valuable-is-the-pca3-test/#comments</comments>
		<pubDate>Tue, 15 Jul 2008 13:41:47 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Diagnosis]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=616</guid>
		<description><![CDATA[Haese et al. have just published data from a prospective, multicenter study of the PROGENSA PCA3 assay as a test for prostate cancer in patients having a repeat biopsy (after one or two prior, negative biopsies). Their conclusion states that, &#8220;The probability of a positive repeat biopsy increases with rising PCA3 scores. The PCA3 score was [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/15/how-valuable-is-the-pca3-test/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Is adjuvant EBRT the new standard for locally advanced disease post-RP?</title>
		<link>http://prostatecancerinfolink.net/2008/07/15/is-adjuvant-ebrt-the-new-standard-for-locally-advanced-disease-post-rp/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/15/is-adjuvant-ebrt-the-new-standard-for-locally-advanced-disease-post-rp/#comments</comments>
		<pubDate>Tue, 15 Jul 2008 12:46:15 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Management]]></category>

		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=614</guid>
		<description><![CDATA[A new review by Ganswindt et al. proposes that patients at high risk for local relapse following first-line radiacal prostatectomy (RP) should receive immediate external beam radiotherapy (EBRT), especially including those patients with positive surgical margins. This seems like a rather provocative recommendation to The &#8220;New&#8221; Prostate Cancer InfoLink. 
The authors state that &#8220;after radical [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/15/is-adjuvant-ebrt-the-new-standard-for-locally-advanced-disease-post-rp/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>The &#8220;Great Prostate Debate&#8221; &#8212; some pluses; some minuses</title>
		<link>http://prostatecancerinfolink.net/2008/07/15/the-great-prostate-debate-some-pluses-some-minuses/</link>
		<comments>http://prostatecancerinfolink.net/2008/07/15/the-great-prostate-debate-some-pluses-some-minuses/#comments</comments>
		<pubDate>Tue, 15 Jul 2008 11:58:18 +0000</pubDate>
		<dc:creator>E. Michael D. ("Mike") Scott</dc:creator>
		
		<category><![CDATA[Diagnosis]]></category>

		<category><![CDATA[Management]]></category>

		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=613</guid>
		<description><![CDATA[The Theragenics Corp. has just announced initiation of a national series (in the USA) of town hall meetings and telephone workshops on prostate cancer under the heading &#8220;The Great Prostate Debate.&#8221; Detailed information about this program is already available online. There are some obvious potential opportunities here to educate and inform men about prostate cancer. [...]]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2008/07/15/the-great-prostate-debate-some-pluses-some-minuses/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/imperativa-128.jpg" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
	</channel>
</rss>